Co-Diagnostics, Inc. (LSE:0A50) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrew Benson | Head of Investor Relations · Since at least Jul 16, 2026 |
| Brent Satterfield | Former Chief Science Officer · Jul 11, 2017 – Feb 23, 2021 · Past |
| Brian Lee Brown | Chief Financial Officer · Since at least May 23, 2025 |
| Carl Wittwer | Chair · Since at least Nov 4, 2026 |
| Christopher Thurston | Chief Technology Officer · Since at least Feb 4, 2026 |
| Daniel Bohrer | EVP of Finance & Accounting · Since at least Sep 2, 2026 |
| David Nielsen | Chief Operations Officer · Since at least Nov 5, 2026 |
| Dwight H. Egan | Chief Executive Officer · Since at least Jul 11, 2017 |
| Edward L Murphy | Director · Since at least Apr 24, 2019 |
| Eugene Durenard | Director · Since at least Jul 11, 2022 |
| Frank J Kiesner | Director · Jul 11, 2017 – Jul 11, 2017 · Past |
| James B Nelson | Director · Since at least Sep 3, 2019 |
| Mayuranki Almaula | Sr. VP Overseas Operations and Strategic Alliances · Since at least Nov 5, 2026 |
| Noriko Kusukawa | Vice President · Since at least Nov 4, 2026 |
| Richard Abbott | President · Since at least Mar 15, 2024 |
| Richard S Serbin | Director · Since at least Jul 11, 2017 |
| Seth Egan | Chief Commercialization Officer · Since at least Sep 23, 2026 |
| Ted Murphy | Director · Since at least Jan 8, 2022 |
| Wes Lindsey | Chief Scientific Officer · Since at least Jul 16, 2026 |
| Wes Lindsey | Chief Scientific Officer · Since Jul 16, 2026 · Appointed, no departure found |